An Investigation of the Effects of Riluzole in Patients With Post-Traumatic Stress Disorder (PTSD)
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Riluzole (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 22 Apr 2016 Planned number of patients changed from 100 to 20.
- 22 Apr 2016 Phase of the trial changed from phase II to phase I. Study design of the trial is changed to open label from double blind along with inclusion of geriatric patients. Accordingly changes in inclusion-exclusion criteria, age keywords. no of arms changed from 2 to 1 (removal of placebo arm).
- 25 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov.